Trump Administration Signals Possible Link Between Tylenol and Autism

Washington, D.C. – September 22, 2025

In a move that has grabbed global attention, President Donald Trump and his administration are set to address concerns regarding a potential connection between Tylenol and autism. The announcement, expected today, could have significant implications for pregnant women, healthcare providers, and the pharmaceutical industry.

According to a report by the Washington Post, Trump is preparing to highlight that the use of acetaminophen—the active ingredient in Tylenol—during pregnancy may contribute to an increased risk of autism in children. Officials are urging pregnant women to limit or avoid the drug in early stages of pregnancy unless it is necessary for fever management.

In addition to issuing warnings about Tylenol, the administration is also drawing attention to leucovorin as a potential therapeutic option for autism. Leucovorin, traditionally used to counteract the harmful effects of methotrexate (a cancer treatment drug) and to prevent or treat certain types of anemia, is now being explored for its possible benefits in addressing autism-related conditions, according to a study published in the National Library of Medicine.

The announcement follows remarks made by Trump at Charlie Kirk’s memorial on Sunday, September 21, where he described the upcoming disclosure as potentially “the biggest medical announcement in our country’s history.” Experts and public health officials are closely watching the development, as the administration prepares for a news conference this afternoon to provide full details.

This move has already sparked debate among medical professionals, parents, and advocacy groups. While some caution that more research is needed to establish a definitive link between acetaminophen and autism, others anticipate that the announcement could influence public behavior, healthcare guidance, and pharmaceutical policies nationwide.

As the news unfolds, it is expected to generate widespread discussion about medication safety during pregnancy and the search for effective interventions for autism spectrum disorder.